Comparative Profiling of Serum Glycoproteome by Sequential Purification of Glycoproteins and 2-Nitrobenzenesulfenyl (NBS) Stable Isotope Labeling: A New Approach for the Novel Biomarker Discovery for Cancer
- 18 August 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 6 (9) , 3475-3483
- https://doi.org/10.1021/pr070103h
Abstract
The recent progress in various proteomic technologies allows us to screen serum biomarker including carbohydrate antigens. However, only a limited number of proteins could be detected by current conventional methods such as shotgun proteomics, primarily because of the enormous concentration distribution of serum proteins and peptides. To circumvent this difficulty and isolate potential cancer-specific biomarkers for diagnosis and treatment, we established a new screening system consisting of the sequential steps of (1) immunodepletion of 6 high-abundance proteins, (2) targeted enrichment of glycoproteins by lectin column chromatography, and (3) the quantitative proteome analysis using 12C6- or 13C6-NBS (2-nitrobenzenesulfenyl) stable isotope labeling followed by MALDI-QIT-TOF mass spectrometric analysis. Through this systematic analysis for five serum samples derived from patients with lung adenocarcinoma, we identified as candidate biomarkers 34 serum glycoproteins that revealed significant difference in α1,6-fucosylation level between lung cancer and healthy control, clearly demonstrating that the carbohydrate-focused proteomics could allow for the detection of serum components with cancer-specific features. In addition, we developed a more simplified and practical technique, mass spectrometry-based glycan structure analysis and lectin blotting, in order to validate glycan structure of candidate biomarkers that could be applicable in clinical use. Our new glycoproteomic strategy will provide highly sensitive and quantitative profiling of specific glycan structures on multiple proteins, which should be useful for serum biomarker discovery. Keywords: biomarker • serum • lung cancer • glycosylation • glycoproteomics • stable isotope labeling • lectin • mass spectrometryKeywords
This publication has 23 references indexed in Scilit:
- A Mutant Chaperone Converts a Wild-Type Protein into a Tumor-Specific AntigenScience, 2006
- Protein biomarker discovery and validation: the long and uncertain path to clinical utilityNature Biotechnology, 2006
- The US Food and Drug Administration perspective on cancer biomarker developmentNature Reviews Cancer, 2006
- Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylationInternational Journal of Cancer, 2006
- Proteomic Analysis of Serum Associated Fucosylated Glycoproteins in the Development of Primary Hepatocellular CarcinomaJournal of Proteome Research, 2006
- Early diagnosis of lung cancer by detection of tumor liberated proteinJournal of Cellular Physiology, 2004
- The Coactivator of Transcription CREB-binding Protein Interacts Preferentially with the Glycosylated Form of Stat5Journal of Biological Chemistry, 2004
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2002
- Chemical GlycobiologyScience, 2001
- Gene expression of α1-6 fucosyltransferase in human hepatoma tissues: A possible implication for increased fucosylation of α-fetoproteinHepatology, 1998